Concordantly, SIM2 was effective to inhibit de novo lipogenesis in ER + BC and TNBC cell lines and effectively inhibited in vivo tumor growth of basal/TNBC tumor models (Fig. 8 and Supplementary Fig. S12). Here, SIM2 is linked to neoplasm.